IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.
Huenecke S, Zimmermann SY, Kloess S, Esser R, Brinkmann A, Tramsen L, Koenig M, Erben S, Seidl C, Tonn T, Eggert A, Schramm A, Bader P, Klingebiel T, Lehrnbecher T, Passweg JR, Soerensen J, Schwabe D, Koehl U.
Huenecke S, et al. Among authors: tramsen l.
J Immunother. 2010 Feb-Mar;33(2):200-10. doi: 10.1097/CJI.0b013e3181bb46f7.
J Immunother. 2010.
PMID: 20145545
Clinical Trial.